Literature DB >> 11371771

Molecular epidemiology of tuberculosis: recent developments and applications.

H A Fletcher1.   

Abstract

The standard method for the typing of Mycobacterium tuberculosis is still IS6110 restriction fragment length polymorphism (RFLP). This method has been widely used and has provided information on the variety and distribution of tuberculosis strain types across the globe. Recently, IS6110 RFLP has been used to investigate the question of reinfection versus reactivation, examine the existence of multiple infection, and track the spread of multidrug-resistant tuberculosis. There have also been efforts to increase our understanding of the biologic characteristics of IS6110. These studies have resulted in a clearer understanding of fingerprinting data and increased our understanding of the evolution and pathogenicity of this organism.

Entities:  

Mesh:

Year:  2001        PMID: 11371771     DOI: 10.1097/00063198-200105000-00007

Source DB:  PubMed          Journal:  Curr Opin Pulm Med        ISSN: 1070-5287            Impact factor:   3.155


  3 in total

1.  Novel multiplex PCR using dual-priming oligonucleotides for detection and discrimination of the Mycobacterium tuberculosis complex and M. bovis BCG.

Authors:  Hye Ryun Lee; So Yeon Kim; Ho Eun Chang; Sang Hoon Song; Hye Seung Lee; Kyoung Un Park; Junghan Song; Eui-Chong Kim
Journal:  J Clin Microbiol       Date:  2010-10-13       Impact factor: 5.948

2.  Molecular epidemiology of tuberculosis in a sentinel surveillance population.

Authors:  Barbara A Ellis; Jack T Crawford; Christopher R Braden; Scott J N McNabb; Marisa Moore; Steve Kammerer
Journal:  Emerg Infect Dis       Date:  2002-11       Impact factor: 6.883

3.  Lewandowsky's Rosaceiform Eruption: a Form of Cutaneous Tuberculosis Confirmed by PCR in Two Patients.

Authors:  Rodrigo Conlledo; Antonio Guglielmetti; Macarena Sobarzo; Francisca Woolvett; Francisca Bravo; Sergio González; Félix Fich; Verónica Vial
Journal:  Dermatol Ther (Heidelb)       Date:  2014-12-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.